Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALStandard

IMURAN

AZATHIOPRINE

Standard Dose
50MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview IMURAN is listed in Drugs@FDA under application 016324 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient AZATHIOPRINE Form and strength TABLET;ORAL - 50MG Sponsor LEGACY PHARMA Submission history Latest submission status date: 2024-07-09 00:00:00.

Structured Monograph

Clinical summary

Approval overview IMURAN is listed in Drugs@FDA under application 016324 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient AZATHIOPRINE Form and strength TABLET;ORAL - 50MG Sponsor LEGACY PHARMA Submission history Latest submission status date: 2024-07-09 00:00:00. Submission type: SUPPL.

Monitoring

  • Marketing status: Prescription
  • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
IMURAN (AZATHIOPRINE) | Drug Monograph | MedicHelpline